have summarized the metrics of the top 10 US Cannabis Stocks as presented in the link below.

NOTES

All Valiues in USD
Net Debt = Cash Minus Debt
Annualized Revenues = Q2/21  X  4

COMMENTS

1....Based on  Adjusted OP Earnings, Hollister's valuation is off the charts

2..Based on Price to Sales, Hollster would be valued at $310 million USD = $390 million cad ( $1.30 per share )

3.. Forward Looking, with its recent order of magnitude increase in Cultivation and Manufacturing space combined with its full entry into the California Cannabis market,  California Revenues in H2 of 2022 should be greater than that of the entire 2021 ( $70 m USD ), with gross margins increasing substantively

4....Forward Fair Valuation at Exit 2022 will approach $1 B USD




https://www.newcannabisventures.com/cannabis-company-revenue-ranking/


 
 
 
 
 
 
 
 
Name
Market Cap
Net debt
Annualized Rev
Y/Y Growth
Adj OP Income
Price to sales
Price to Op Income
 
 
 
 
 
 
 
 
Scotts Mir Grio
$9.1 b
-$3.5 b
$1.7 b
48%
$37.8 m
5.4
1680
Curaleaf
$9.1 b
- $0.6 b
$1.3 b
166%
$22.6 m
7.3
1250
Green Thumb
$7.4 b
-$50 m
$0.89 b
85%
$50.9 m
8.3
890
Trulieve
$2.0 b
-$20 mm
$0.86 b
78%
$83.0 m
2.3
860
Cresco Labs
$2.7 b
-$275 m
$0.84 b
123%
$14.9 m
3.2
840
Verano Holdings
$1.8 b
-$260 m
$0.80 b
320%
$43.1 m
2.2
790
Hydrofarm
$2.1 b
nil
$0.54 b
47%
$6.4 m
3.9
540
Grow Generation
$1.9 b
nil
$0.56 b
190%
$9.6 m
3.8
5600
Harvest Health
$1.1 b
-$175 m
$0.41 b
84%
$11.3 m
2.6
410
Columbia Care
$1.9 b
-$450 m
$0.41b
260%
-$8.2 m
4.6
500
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
4.4
860
 
 
 
 
 
 
 
 
Hollister
$82 m
$5 m
$70 m
107%
$25.0 m
1.2
3.3
 
 
 
 
 
 
 
 
HOLL Valuation
 
 
 
 
 
$310 m
$1 b +